Showing results (291-300 of 463) with videos related to
Sort By:
Pageof 47
Cancer Research|October 6, 2005
Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancerSanjeev Banerjee, Yuxiang Zhang, Shadan Ali, et al.British Journal of Cancer|February 1, 1992
A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposideP A Philip, S Joel, S C Monkman, et al.American Journal of Clinical Oncology|June 5, 2010
Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experienceNazik Hammad, Lance K Heilbrun, Sachin Gupta, et al.Indian Journal of Microbiology|July 4, 2012
Copper, Zinc-Superoxide Dismutase from Clinically Isolated Escherichia coli: Cloning, Analysis of sodC and Its Possible Role in PathogenicityM K Sanjay, S M Srideshikan, V L Vanishree, et al.Journal of Gynecology Obstetrics and Human Reproduction|May 15, 2023
Surgical management of a loss of pregnancy in the first trimester: Patient experience and influencing factors, a prospective observational studyT Toutain, C-A Philip, L Bollon, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I study of intravenous 4-hydroxyanisoleG J Rustin, M R Stratford, A Lamont, et al.European Journal of Cancer (Oxford, England : 1990)|May 7, 2013
Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancerPhilippe Rougier, Hanno Riess, Robert Manges, et al.Cancers|July 2, 2021
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to BedsideMd Hafiz Uddin, Mohammed Najeeb Al-Hallak, Philip A Philip, et al.Future Oncology (London, England)|September 13, 2019
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreasPhilip A Philip, Marc E Buyse, Angela T Alistar, et al.Molecular Cancer Therapeutics|October 5, 2007
Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cellsK M Wahidur Rahman, Shadan Ali, Amro Aboukameel, et al.Pageof 47